Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00658970 · ClinicalTrials.gov registry record · Phase 1
Evaluation of KX2-391 in Patients With Advanced Malignancies
A Phase 1 study, sponsored by Athenex.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT00658970 is a Phase 1 study that has completed, run by Athenex. The registered enrollment target is 50 participants.
The verdict
NCT00658970, a Phase 1 study, has completed, sponsored by Athenex.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this Phase 1 study is to determine the safety and tolerability of KX2-391 in cancer patients.
Interventions
- DRUG KX2-391
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00658970
The ClinicalTrials.gov registry entry for NCT00658970 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Athenex, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KX2-391 is the first listed.
NCT00658970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00658970 about?
NCT00658970 is a clinical study titled "Evaluation of KX2-391 in Patients With Advanced Malignancies". The purpose of this Phase 1 study is to determine the safety and tolerability of KX2-391 in cancer patients.
What is the current status of trial NCT00658970?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2007-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00658970?
The interventions under investigation include: KX2-391 (DRUG).
Who is sponsoring clinical trial NCT00658970?
This trial is sponsored by Athenex, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.